Dupilumab Significantly Reduces Itch and Hives in Patients With Chronic Spontaneous Urticaria: Results From a Phase 3 Trial (LIBERTY-CSU CUPID Study A)

M. Maurer, T. Casale, S. Saini, M. Ben-Shoshan, N. Amin, A. Radin, B. Akinlade, C. Fan, D. Bauer, E. Laws, L. Mannent, Aleksandra Stjepanovic

2022.2.1JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

DOI: 10.1016/j.jaci.2021.12.002

Abstract

Abstract is not available.

Citation format

MAURER, M., et al. Dupilumab significantly reduces itch and hives in patients with chronic spontaneous urticaria: Results from a phase 3 trial (LIBERTY-CSU CUPID study a). JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022.